Irma Bagdoniene on NEJM-Published VESALIUS-CV: 25% Fewer First CV Events
Irma Bagdoniene, Cardiologist and Lipidologist at Klinikum Lippe – University Hospital for Cardiology, Angiology, and Internal Intensive Care Medicine, posted on LinkedIn:
”VESALIUS-CV at AHA:
The Room Was Applauding – And Not Without Reason
Presented at the AHA Congress and now published in NEJM, VESALIUS-CV marks a turning point in preventive cardiology.
In patients without prior MI or stroke, evolocumab reduced first major cardiovascular events by 25% — safely and decisively.
LDL lowering works – and earlier intervention saves lives.
When an entire audience of cardiologists applauds, it’s not hype. It’s the sound of a paradigm shifting.”
Read the full article here.
Title: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
Authors: Erin A. Bohula, D.Phil., Nicholas A. Marston, Ajay K. Bhatia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Jeong-Gun Park, Julia F. Kuder, Sabina A. Murphy, Emileigh Walsh, Huei Wang, Vladimir Blaha, Andrzej Budaj, Jan H. Cornel, Assen Goudev, Robert Gabor Kiss, Alberto J. Lorenzatti, Alexander Parkhomenko, Marcoli Cyrille, Gabriel Paiva da Silva Lima, E. Magnus Ohman, Robert P. Giugliano, Marc S. Sabatine
Stay updated with Hemostasis Today.
-
Mar 14, 2026, 13:44Isabelle Mahé: Bleeding Risk Differs Across Solid Tumours in Cancer-Associated Thrombosis
-
Mar 14, 2026, 13:24Peter Zdziarski: Robotic Hysterectomy Brings Hope for Glanzmann Thrombasthenia Patients
-
Mar 14, 2026, 12:59Giuseppe Lippi: New Highlights on Key Aspects of Heparin Anticoagulant Therapy and Monitoring
-
Mar 14, 2026, 12:39Samwel Mikaye: Blood Smear Morphology Guide
-
Mar 14, 2026, 12:24Pradeep Natarajan: Key New Aspects of the 2026 ACC/AHA Dyslipidemia Guidelines
-
Mar 13, 2026, 22:57Robert Hamilton: The Reality of Stroke Care and Why 81.6% Should be a Wake-Up call
-
Mar 13, 2026, 22:05Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
-
Mar 13, 2026, 21:29Timothy Glidewell: Genetic Signals of Platelet and Clotting Pathways in Cryptogenic Stroke
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH